Hacker News with Generative AI: HIV

Long-acting injectable HIV therapy offers hope for those unable to take pills (medicalxpress.com)
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UCSF has found.

HIV, Medicine, Health, Research, Treatment

7 points by PaulHoule 38 days ago | 1 comments

Atul Gawande: Hundreds of Thousands Will Die (newyorker.com)
The internal estimates are that more than a hundred and sixty thousand people will die from malaria per year, from the abandonment of these programs, if they’re not restored. We’re talking about twenty million people dependent on H.I.V. medicines—and you have to calculate how many you think will get back on, and how many will die in a year. But you’re talking hundreds of thousands in Year One at a minimum.

Health, Public Health, Malaria, HIV, Global Health

22 points by mitchbob 41 days ago | 1 comments

Cancer-fighting compound shows immense potential to eradicate HIV (news.stanford.edu)

Cancer, HIV, Medicine, Science, Research

3 points by nkzednan 73 days ago | 0 comments

The Charlie Sheen effect on HIV testing (2017) (sciencedaily.com)
On November 17, 2015, actor Charlie Sheen publicly disclosed he was HIV-positive on NBC's Today Show.

HIV, Public Health, Celebrities, Media Impact, Science

43 points by stevekemp 87 days ago | 15 comments

Twice-Yearly HIV Shot Shows 100% Effectiveness in Women (apnews.com)
It’s been called the closest the world has ever come to a vaccine against the AIDS virus.

HIV, Medical Research, Health, Vaccines

249 points by bear_with_me 144 days ago | 146 comments

Viral trapdoor: Scientists discover how a protein protects against HIV, herpes (medicalxpress.com)
A group of researchers discovered how a protein linked to the human immune system wards off HIV-1 and herpes simplex virus-1 by assembling structures in the cell that lure in these viruses and then trap them or even take them apart.

HIV, Herpes, Immunology, Viral Research, Science

6 points by PaulHoule 180 days ago | 1 comments

Gilead agrees to license twice-yearly HIV drug for poor countries (statnews.com)
In response to increased criticism of its pricing, Gilead Sciences has reached voluntary licensing deals with companies to make generic versions of its twice-yearly HIV medicine, lenacapavir, in 120 mostly low- and lower-middle-income countries.

HIV, Pharmaceuticals, Licensing, Healthcare, Global Health

14 points by divbzero 205 days ago | 0 comments

Gilead's twiceyearly shot cut HIV infections by 96% in trial (cnbc.com)

HIV, Medicine, Health, Clinical Trials

4 points by jackallis 226 days ago | 0 comments

HIV drug could be made for just $40 a year for every patient (theguardian.com)

HIV, Healthcare, Cost, Medicine, Drugs

66 points by nithinj 260 days ago | 88 comments

Engineered Virus Steals Proteins from HIV, Pointing to New Therapy (nytimes.com)

Viruses, HIV, Medical Research, Therapeutics

3 points by aussieguy1234 260 days ago | 2 comments

Prevention of HIV (science.org)